Sponsor:
Dar Clinical Research Inc.
Code:
NCT07710014
Conditions
Attention Deficit Hyperactivity Disorder
Eligibility Criteria
Sex: All
Age: 65+
Healthy Volunteers: Not accepted
Interventions
Methylphenidate hydrochloride extended-release capsules
Brief summary:
Conditions
Attention Deficit Hyperactivity Disorder
Study ID
NCT07710014
Start date
Oct 6, 2026
Status verified date
Oct, 2026
Completion date
Jul 21, 2027
Anticipated
Primary completion date
Jul 21, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 65+
Healthy Volunteers: Not accepted
Enrollment
36 participants
Anticipated
Intervention Model
Single group
Primary purpose
Treatment
Arms
experimental: Foquest (Multilayer-Release Methylphenidate)
Interventions
Methylphenidate hydrochloride extended-release capsules
Primary outcome measure
Central contacts
Locations
DAR Clinical Research Inc.
Recruiting
Ottawa, Ontario, Canada, K2J 3Z6
Sponsor
Dar Clinical Research Inc.
Last update posted
Oct 7, 2026
Last verified
Oct, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-10-08. This information was provided to ClinicalTrials.gov by Dar Clinical Research Inc. on 2026-10-07. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.